Consider whether a specialist referral to an obesity medicine physician or endocrinologist would be appropriate
Wegovy (semaglutide 2.4 mg) is a prescription-only medication licensed in the UK for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes or hypertension
Online and mail-order programs offering compounded semaglutide vs brand name medications at dramatically reduced prices are increasingly operating outside FDA-compliant sourcing requirements
Coverage depends on your insurance, and again, coverage is very unlikely for weight loss: Private insurance usually covers Januvia, but only for type 2 diabetes, not weight loss
Adjustment Phase After the initial phase, the dose is usually increased to 5 mg once a week for 4 weeks, followed by a second increase to 7.5 mg once a week
This system controls the desire to pursue food, not just the physical sensation of hunger